Page 6 - Stocks Technical Analysis

DLF, Macrotech Developers: Realty stocks remain resilient amid sell-off

Since the start of the current year, the Nifty Realty pack has remained laggard and traded with a weak bias down 1.5 cent lower so far in 2023.

Here's why Vinay Rajani recommends to buy SBI Life, Indian Oil

On the broader market outlook, the technical & derivative analyst from HDFC Securities expects the near term trend on the Nifty to remain bearish as long as the index stays below 18,141.

Mehul Kothari recommends to buy Laurus Labs, RateGain Travel Technologies

According to the technical analyst from Anand Rathi, Laurus Labs can rally to Rs 400; while RateGain can jump to Rs 330.

TCS, HCL Tech, Infy: How to trade IT stocks ahead of Q3 results?

The overall trend in the IT stocks have remained laggard and continues to bear high risk element.

Nifty IT index likely to consolidate, FMCG looks weak, says Ravi Nathani

According to the technical analyst, the IT index is expected to consolidate between 30,600 - 26,300 range.

Bajaj twins need to sustain these key levels to prevent extended selloff

The broader trend in Bajaj Finance and Bajaj Finserv stocks has turned weak and if both these stocks fail to rebound overcoming key levels, the sell-off could intensify.

F&O Call: Nandish Shah recommends to long Glenmark Pharma futures

The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.

Watch out for these key levels on HDFC Life, ICICI Pru, says Mehul Kothari

According to the technical analyst from Anand Rathi, HDFC Life can jump to Rs 660; while ICICI Prudential Life can rally to Rs 510.

SC relief fails to cheer multiplex stocks; PVR, Inox trend may turn bearish

PVR and Inox Leisure stocks must defend key levels to avoid turning bearish, show technical charts

Vinay Rajani recommends to buy HCC, Nava as stocks crossed key resistances

On the broader market outlook, the technical & derivative analyst from HDFC Securities suggests that the trend for Nifty is still bearish.

Mehul Kothari is bullish on Linde India, Saregama; check why

According to the technical analyst from Anand Rathi, Linde India can rally to Rs 3,875; while Saregama can surge to Rs 425.

F&O Call: Nandish Shah recommends Bull Spread strategy on Bharat Forge

The derivative analyst from HDFC Securities recommends to Buy Bharat Forge 880 Call and simultaneously Sell 900 Call for the January expiry.

Metro Brands, Bayer Crop are ready for range breakout, says Mehul Kothari

According to the technical analyst from Anand Rathi, Metro Brands can rally to Rs 910; while Bayer Cropscience can surge to Rs 5,200.

Vinay Rajani recommends to hold longs on Nifty with a stop at 17,800

Among individual stocks, the technical & derivative analyst from HDFC Securities recommends buying RCF and NCC.

Sugar stocks to sweeten in 2023; Dwarikesh, Renuka can rally up to 37%

The stellar performance of sugar stocks began in 2021, and is likely to continue in the new year - 2023, indicates the technical charts.

Nifty, Bank Nifty see higher rollover; Hero MotoCorp, HDFC Life find favour

However, the overall market wide position dipped below Rs 2.20 lakh crore for the first time in the last six months.

Here's why Mehul Kothari recommends to buy ABB, MRPL

According to the technical analyst from Anand Rathi, ABB can advance to Rs 2,880; while MRPL can jump to Rs 57.

Indigo, SpiceJet: After a dismal 2022, will aviation stocks soar in 2023?

Indigo and SpiceJet shares must surpass these key hurdles to embark on a new trend.

Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%

Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.

Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains

According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.